165 related articles for article (PubMed ID: 2214155)
1. [Chemotherapy and endocrine therapy of endometrial carcinoma].
Kanuma T; Matsuzawa M
Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
Turbow MM; Ballon SC; Sikic BI; Koretz MM
Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
5. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
6. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
7. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
Bokhman IaV; Volkova AT; Chepik OF; VishnevskiÄ AS
Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650
[No Abstract] [Full Text] [Related]
8. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
9. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.
Levin L; Hryniuk W
Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317
[TBL] [Abstract][Full Text] [Related]
10. Effects of progestational agents in treatment of endometrial carcinoma.
Podratz KC; O'Brien PC; Malkasian GD; Decker DG; Jefferies JA; Edmonson JH
Obstet Gynecol; 1985 Jul; 66(1):106-10. PubMed ID: 4011061
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients.
Pasmantier MW; Coleman M; Silver RT; Mamaril AP; Quiguyan CC; Galindo A
Cancer Treat Rep; 1985 May; 69(5):539-42. PubMed ID: 4039980
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
13. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).
Price FV; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1993 Dec; 51(3):383-9. PubMed ID: 8112650
[TBL] [Abstract][Full Text] [Related]
14. [A randomized trial of endocrine therapy, chemotherapy, and chemo-endocrine therapy in advanced breast cancer].
Tashiro H; Nomura Y; Hisamatsu K
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2369-73. PubMed ID: 2260873
[TBL] [Abstract][Full Text] [Related]
15. [Palliative chemotherapy of endometrial cancer. Value of combinations with doxorubicin and cisplatin].
Chauvergne J; Granger C; Mage P; Pigneux J; David M
Rev Fr Gynecol Obstet; 1986 Oct; 81(10):547-51. PubMed ID: 2431448
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
17. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122.
Randall ME; Spirtos NM; Dvoretsky P
J Natl Cancer Inst Monogr; 1995; (19):13-5. PubMed ID: 7577198
[TBL] [Abstract][Full Text] [Related]
18. [A case of total regression of endometrial carcinoma metastases in the lung under hormonal therapy (author's transl)].
Caminati M; Hauser GA
Ther Umsch; 1979 Jun; 36(6):516-7. PubMed ID: 462406
[No Abstract] [Full Text] [Related]
19. [Hormonal therapy in endometrial cancer].
Kanoh H; Okudaira Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2306-10. PubMed ID: 8259843
[TBL] [Abstract][Full Text] [Related]
20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]